Income Tax Act, 1962 (Act No. 58 of 1962)Notices2015 NoticesNotice in terms of section 11D(6)(b) in respect of certain categories of Research and Development deemed to constitute the carrying on of Research and DevelopmentNotice No. R. 343 of 2015 |
Notice No. R. 343
23 April 2015
GG 38729
National Treasury
I, Nhlanhla Musa Nene, Minister of Finance, hereby give notice in terms of section 11D(6)(b) of the Income Tax Act, 1962 (Act No. 58 of 1962), that—
| (a) | creating or developing a multisource pharmaceutical product, as defined in the World Health Organisation Technical Report Series, No. 937, 2006 Annex 7 Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish inter-changeability issued by the World Health Organisation, conforming to such requirements as must be prescribed by regulations made by the Minister of Finance after consultation with the Minister of Science and Technology; and |
| (b) | conducting a clinical trial as defined in Appendix F of the Guidelines for good practice in the conduct of clinical trials with human participants in South Africa issued by the Department of Health (2006), conforming to such requirements as must be prescribed by regulations made by the Minister of Finance after consultation with the Minister of Science and Technology, |
are deemed to constitute the carrying on of research and development for the purposes of section 11D of the Income Tax Act, 1962 (Act No. 58 of 1962).
Nhlanhla Musa Nene
Minister of Finance
Date: